Search

Your search keyword '"Purpura metabolism"' showing total 40 results

Search Constraints

Start Over You searched for: Descriptor "Purpura metabolism" Remove constraint Descriptor: "Purpura metabolism"
40 results on '"Purpura metabolism"'

Search Results

1. Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.

2. Ethylmalonic encephalopathy masquerading as meningococcemia.

3. Lymphomatoid papulosis type E with a CD56+ immunophenotype presenting with purpura-like lesions.

4. Bateman purpura (dermatoporosis): a localized scurvy treated by topical vitamin C - double-blind randomized placebo-controlled clinical trial.

5. Bioenergetics dysfunction, mitochondrial permeability transition pore opening and lipid peroxidation induced by hydrogen sulfide as relevant pathomechanisms underlying the neurological dysfunction characteristic of ethylmalonic encephalopathy.

6. Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

7. Untargeted Metabolomics Analysis Reveals a Link between ETHE1-Mediated Disruptive Redox State and Altered Metabolic Regulation.

8. Quantitative proteomics suggests metabolic reprogramming during ETHE1 deficiency.

9. Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.

10. Periorbital purpura (raccoon's eyes).

11. Cocaine-associated retiform purpura: a C5b-9-mediated microangiopathy syndrome associated with enhanced apoptosis and high levels of intercellular adhesion molecule-1 expression.

12. Gastrointestinal and hepatic manifestations of mitochondrial disorders.

13. Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy.

14. Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.

15. Ethylmalonic encephalopathy associated with crescentic glomerulonephritis.

16. Granulomatous pigmented purpura: report of a case and review of the literature.

17. Persistent pigmented purpuric dermatitis: granulomatous variant.

18. Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy.

19. Foxp3 expression in cutaneous T-cell lymphocytic infiltrates.

20. Vitality and age of conjunctival petechiae: the expression of P-selectin.

21. Assessment of TCR-beta clonality in a diverse group of cutaneous T-Cell infiltrates.

22. Purpuric eruption on the finger.

23. An immunohistopathologic study in cutaneous necrotizing vasculitis.

24. An ultrastructural study of pigmented purpuric dermatitis with special reference to fibrous long-spacing collagen.

25. Large annular purpura and paraneoplastic purpura in a patient with Sjögren's syndrome and cervical cancer.

26. Assessment of pulmonary and intrathymic hemosiderin deposition in sudden infant death syndrome.

27. Severe type I protein C deficiency in a compound heterozygote for Y124C and Q132X mutations in exon 6 of the PROC gene.

28. Cell adhesion molecule expression in capillaritis.

29. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency.

30. Cellular adhesion antigen modulation in purpura pigmentosa chronica.

31. Expression of an immunoreactive 72 kDa protein in strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

33. Antihyaluronidase level in children with rheumatic fever and other streptococcal infection.

36. Albumin synthesis rates in patients with hypoproteinemia.

38. Tissue-bound tryptophan-rich protein appearing in allergic vasculitis.

39. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis.

40. Heparin precipitable fraction in necrotizing vasculitis.

Catalog

Books, media, physical & digital resources